Starling Oncology, Inc. Warrant

STLNW

Market cap $5.04M

STLNW Hedge Fund Activity: Q1 2026 in Review

11 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q1 2026, worth a combined $479K — down 42% from $821K a quarter earlier.

Fund positioning in STLNW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Wolverine Asset Management, adding an estimated $399.

• 11 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q1 2026, unchanged from Q4 2025.
• Funds reported $479K of Starling Oncology, Inc. Warrant stock for Q1 2026, down 42% quarter-over-quarter.
• 0 funds opened new Starling Oncology, Inc. Warrant positions in Q1 2026 and 0 closed out.
• The largest Starling Oncology, Inc. Warrant buyer in Q1 2026 was Wolverine Asset Management, an estimated $399 added.

Based on aggregated 13F filings for Q1 2026.